Skip to main content
Premium Trial:

Request an Annual Quote

Fiction About Science, Not Science Fiction

Not to be confused with science fiction, "in which the action takes place in speculative worlds and may not involve scientist characters," Jennifer Rohn writes in Nature that "lab lit," or "realistic novels that contain scientists as central characters plying their trade," is increasing in popularity. "Rather than reflecting society's hopes and fears about technology as science fiction does, lab lit tends to focus on the intricacies of scientific work and scientists as people," Rohn writes. Still, the editor of says that, when compared with more popular genres — such as crime fiction, which generates around 600 new books per year in the UK — lab lit falls short, though it is on the subtle rise. "The number of lab-lit books has risen dramatically in the past two decades," she writes, adding that in her studies, she has identified 118 lab lit novels published since 1900, and, since the 1980s, five to 10 lab lit novels were published each year.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.